David Shaw’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,714
| Closed | -$2.57M | – | 5197 |
|
|
2021
Q1 | $2.57M | Sell |
21,714
-8,703
| -29% | -$1.03M | ﹤0.01% | 2378 |
|
|
2020
Q4 | $3.59M | Sell |
30,417
-6,690
| -18% | -$777K | ﹤0.01% | 2123 |
|
|
2020
Q3 | $4.12M | Buy |
37,107
+8,506
| +30% | +$913K | ﹤0.01% | 1839 |
|
|
2020
Q2 | $2.92M | Sell |
28,601
-5,857
| -17% | -$627K | ﹤0.01% | 2103 |
|
|
2020
Q1 | $3.72M | Sell |
34,458
-17,327
| -33% | -$1.99M | 0.01% | 1685 |
|
|
2019
Q4 | $6.03M | Sell |
51,785
-2,500
| -5% | -$290K | 0.01% | 1587 |
|
|
2019
Q3 | $6.21M | Buy |
54,285
+10,813
| +25% | +$1.08M | 0.01% | 1477 |
|
|
2019
Q2 | $4.14M | Sell |
43,472
-65,615
| -60% | -$6.18M | 0.01% | 1718 |
|
|
2019
Q1 | $9.95M | Sell |
109,087
-18,573
| -15% | -$1.52M | 0.01% | 1107 |
|
|
2018
Q4 | $9.69M | Buy |
127,660
+27,213
| +27% | +$2M | 0.01% | 1108 |
|
|
2018
Q3 | $8.04M | Sell |
100,447
-79,026
| -44% | -$7.36M | 0.01% | 1241 |
|
|
2018
Q2 | $17.8M | Buy |
179,473
+74,459
| +71% | +$6.43M | 0.02% | 776 |
|
|
2018
Q1 | $8.51M | Sell |
105,014
-78,255
| -43% | -$6.33M | 0.01% | 1096 |
|
|
2017
Q4 | $14.4M | Buy |
183,269
+85,135
| +87% | +$7.08M | 0.02% | 823 |
|
|
2017
Q3 | $9.05M | Buy |
98,134
+93,307
| +1,933% | +$8.97M | 0.01% | 1004 |
|
|
2017
Q2 | $546K | Sell |
4,827
-1,285
| -21% | -$144K | ﹤0.01% | 2773 |
|
|
2017
Q1 | $612K | Sell |
6,112
-215
| -3% | -$23K | ﹤0.01% | 2623 |
|
|
2016
Q4 | $680K | Sell |
6,327
-1,005
| -14% | -$117K | ﹤0.01% | 2690 |
|
|
2016
Q3 | $913K | Sell |
7,332
-4,477
| -38% | -$529K | ﹤0.01% | 2439 |
|
|
2016
Q2 | $1.26M | Sell |
11,809
-10,954
| -48% | -$1.27M | ﹤0.01% | 2266 |
|
|
2016
Q1 | $2.61M | Sell |
22,763
-19,985
| -47% | -$2.34M | ﹤0.01% | 1699 |
|
|
2015
Q4 | $6.09M | Buy |
42,748
+15,934
| +59% | +$1.84M | 0.01% | 1267 |
|
|
2015
Q3 | $2.41M | Sell |
26,814
-68,772
| -72% | -$7.26M | ﹤0.01% | 1949 |
|
|
2015
Q2 | $11M | Buy |
95,586
+59,332
| +164% | +$6.23M | 0.02% | 971 |
|
|
2015
Q1 | $3.46M | Buy |
36,254
+6,680
| +23% | +$500K | 0.01% | 1636 |
|
|
2014
Q4 | $1.99M | Sell |
29,574
-8,680
| -23% | -$538K | ﹤0.01% | 2292 |
|
|
2014
Q3 | $2.06M | Buy |
38,254
+27,640
| +260% | +$1.36M | ﹤0.01% | 2220 |
|
|
2014
Q2 | $472K | Buy |
+10,614
| New | +$434K | ﹤0.01% | 3578 |
|
David Shaw's CBPO Position: Q2 2021 in Review
David Shaw sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 21,714 shares — an estimated $2.57M sold.
David Shaw first reported a position in CBPO in Q2 2014 and held it in 28 quarters. The position peaked at $17.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- David Shaw reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- David Shaw sold 21,714 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.57M.
- David Shaw first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 28 quarters.
- David Shaw's China Biologic Products Holdings, Inc. position peaked at $17.8M in Q2 2018.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.